besity has recently emerged as a global health concern. Patients with metabolic syndrome, which is associated with clinical disorders based on abdominal obesity, including atherogenic dyslipidemia, hypertension, and hyperglycemia and/or insulin resistance, are now recognized as a high-risk group for cardiovascular diseases (CVD). 1,2
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International committees disagree on the definition, including cutoff points for waist circumference (WC), used in the diagnosis of metabolic syndrome. In its diagnostic criteria, the National Cholesterol Education Program Adult Treatment Panel III (ATPIII) adopted abdominal obesity defined by WC instead of body mass index (BMI) as 1 of 5 factors in addition to elevated triglycerides, reduced high-density lipoprotein-cholesterol, hypertension and hyperglycemia. Although obesity itself was not included as an essential component in the ATPIII definition, it was given equal weight to the 5 risk factors. 1 In contrast, the definition of metabolic syndrome according to the Japanese Committee regards obesity as the essential factor that induces several metabolic disorders. 2 This discordance reflects differences in how WC is treated; it is viewed as an anthropometric marker for measuring visceral fat mass by some groups, whereas others consider it a surrogate marker of patients at high-risk for CVD.
There are several advantages and disadvantages of the current methods used for the estimation of visceral fat mass. Computed tomography (CT) scan is more accurate than other methods, but is costly and associated with a risk of radiation exposure. Underwater weighing, dual energy X-ray absorptiometry, and magnetic resonance imaging are also expensive and inconvenient for use as screening or in general health checkups. 3, 4 In contrast, measurement of WC is a more convenient method than calculating BMI for classifying fat accumulation and has therefore been included as an essential factor in the definition of metabolic syndrome in Japan. 2 WC itself, however, is known to fluctuate and its definition is up for debate because its measurement includes not only visceral, but also subcutaneous fat.
In this issue of the journal, Yamashita et al report that in middle-aged Japanese male workers that body fat percentage (BF%), measured by bioelectrical impedance analysis (BIA), could detect subjects with 1 or 2 CVD risk factors more accurately than BMI. 5 BIA is widely accepted as a safe, rapid, low cost and reliable technique for measuring BF% and is currently being used at home and in medical health checkups for screening and in the measurement of an individual's body composition. Recent reports have demonstrated that BF% is closely associated with CVD risk factors such as hypertension, dyslipidemia, and abnormal glucose metabolism. 3,4,6, 7 One major concern with the use of BIA is that it is an indirect measure of body composition. BIA is based on the principle that electric current flows at different rates through the body according to its tissue composition; for example, fat impedes electric current more than protein. 3,4,6,7 A number of predictive equations derived from empirical data have been developed for the estimation of BF% using BIA of tissue impedance and reactance. These data vary, however, according to age, ethnic group, and body shape. It is therefore necessary to choose from several validated equations to find the one that is best suited to the population being studied. 3 Furthermore, variability in consumption of food or drink, exercise, existence of edema in the extremities or ascites, skin temperature, menstrual cycle and menopause can affect BF%. 4 Differences among the equipment used may also affect this analysis. All these factors make it impossible to have a "universal equation" for use in all populations 6 and for this reason, BIA should only be considered as an option for body composition analysis in healthy individuals or in patients with no fluid imbalance or body shape abnormalities, who have a BMI between 16 and 34 kg/m 2 . 7 Furthermore, appropriate equations (age-, sex-and ethnic group-specific) should be used.
Yamashita et al recognized these limitations and performed their measurements of BF% under controlled conditions. Measurements were performed on Japanese males in the fasted state before work in the morning using the same body composition analyzer. This instrument has previously been validated for use in a Japanese population. 5 Using a method similar to their protocol, my group has also performed general health checkups among company employees (males) and demonstrated that individual counseling for diet and exercise significantly reduced BF% as well as BMI, WC, and blood pressure levels. 8 It is therefore important that investigators who use BIA to measure BF% assess subjects in the fasted state and use similar methods as those reported here. 5 An interesting aspect of this study is that Yamashita et al report lower BIA cutoff points in the detection of CVD risk factors in current smokers than in nonsmokers. 5 This unique FUJIOKA Y method of determining cutoff points according to smoking status (current, ever or nonsmoking) should be considered in future clinical investigations.
It may be necessary to assess the distribution of body fat, particularly visceral fat, as distinguished from a simple assessment of obesity. A new method of BIA was recently reported by Ryo et al, who have developed an abdominal BIA method to noninvasively estimate visceral fat area (eVFA), and they showed that eVFA presumed by abdominal BIA correlated significantly with VFA determined by CT. 9 This correlation was stronger than correlations between VFA determined by CT and WC, BMI and BF% × weight measured by the conventional BIA method. 9 Okauchi et al used this abdominal BIA method in 2,870 Japanese (males: 2,322; females: 548) and demonstrated that in the receiver-operating characteristic curve, the cutoff points for predicting the prevalence of ≥1 CVD risk factors were 25 kg/m 2 and 28 kg/m 2 for BMI and 85 cm and 95 cm for WC in males and females, respectively. 10 It is very interesting to compare these cutoff points with the data presented by Yamashita et al in this issue of the Journal. 5 In their study, the cutoff points for detecting the prevalence of ≥1 risk factor were 22.7 kg/m 2 for BMI, 81.4 cm for WC, and 20.3% for BF%; those for detecting the presence of 3 risk factors in current smokers were 24.9 kg/m 2 , 87.8 cm, and 23.7%, respectively, and 23.3 kg/m 2 , 83.9 cm and 22.3% for BMI, WC and BF%, respectively, in nonsmokers. The results from these 2 papers 5,10 may become the model for future clinical cohort studies or intervention trials using BIA.
Studies seeking better parameters for assessment of disease recently reported that phase angle (PA), a parameter of BIA, was a prognostic marker for survival in several clinical conditions including chronic obstructive pulmonary disease, 11 heart failure, 12 and cancer, 13 suggesting that PA is a recognized parameter in the estimation of both body composition and function. PA, an indicator based on reactance and resistance obtained from BIA, is independent of regression equations, although it is lower in women and in individuals who are not physically active, and decreases with age. 3 In summary, Yamashita et al show that in middle-aged Japanese male workers, BF% measured by BIA could detect the presence of 2 or more CVD risk factors more accurately than BMI, and suggest that current smokers have lower BIA cutoff points than nonsmokers for detecting individuals with CVD risk factors. Although further study is necessary to confirm the significance of their measurements of BF%, the methods, results and cutoff points presented are worth referencing in future studies.
